Estudo de laboratório sugere que as vacinas mRNA contra COVID podem bloquear as variantes que atingem a Ásia – “Ensaios usando SARS-CoV-2 vivo são esperança de que as vacinas feitas pela Pfizer e pela Moderna protejam contra a cepa viral vista pela primeira vez na Índia.”

COVID vaccines can block variant hitting Asia, lab study finds – Nature

Ver também: Pfizer, Moderna vaccines effective against Indian variants: study – MedicalXpress

Comentário no Twitter

Pfizer & Moderna mRNA vaccines are effective against multiple SARSCoV2 variants, including the B.1.617 & B.1.618, 2 variants underlying the surge in India. The research, while not yet peer-reviewed, was conducted at NYU School of Medicine in New York City https://t.co/3ziRhk8f4t pic.twitter.com/VzYQKWqyQF

— delthia ricks 🔬 (@DelthiaRicks) May 17, 2021